Search Login Register
Integrins
Summary
Description:
A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors(RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.
Key Diseases for which Integrins is
Relevant
-
Neoplasms (Cancer)
:
10 outcomes 82 studies in 989 results
-
Glioma (Gliomas)
:
4 outcomes 8 studies in 52 results
-
Infection
:
3 outcomes 14 studies in 181 results
-
Multiple Sclerosis
:
3 outcomes 1 study in 17 results
-
Prostatic Neoplasms (Prostate Cancer)
:
2 outcomes 15 studies in 64 results
Show All >>
Drugs Related to Integrins
-
Ligands
-
arginyl-glycyl-aspartic acid
-
Collagen
-
Peptides
-
Fibronectins (Fibronectin)
-
Cilengitide
-
Antigens
-
Integrin alphaVbeta3
-
EMD 121974
-
Monoclonal Antibodies
Show All >>
Therapies Related to Integrins
-
Therapeutics
-
Castration
-
Immunotherapy
-
Transplantation (Transplant Recipients)
-
Heterologous Transplantation (Xenotransplantation)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.